December 8, 2025 3:47 PM
New Antibody Therapy Shows Promise for Myeloma
An immune- and cancer cell-targeting antibody therapy has shown potential to eliminate residual traces of multiple myeloma, a deadly blood cancer, according to interim results from a clinical trial. The trial involved 18 patients who received up to six cycles of the bispecific antibody linvoseltamab. Highly sensitive tests revealed no detectable disease in any of the participants, according to findings presented at the American Society of Hematology (ASH) annual meeting in Orlando, US. The ear...


